What is the ticker symbol for Kintara Therapeutics?

Kintara Therapeutics trades under the ticker KTRA on NASDAQ.

What sector does Kintara Therapeutics operate in?

Kintara Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KTRA in a portfolio?

PortView shows KTRA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Kintara Therapeutics (KTRA) Stock Analysis

NASDAQHealthcareBiotechnology

$0.22-6.31%

1-year price historyRange $0.22 – $37.89

52-week range$0.22

$0.20$26.21

What Kintara Therapeutics does

Kintara Therapeutics, Inc. operates as a clinical-stage biotechnology firm, dedicated to pioneering and commercializing anti-cancer treatments for patients. Central to its pipeline are two compounds nearing Phase III trials. One, VAL-083, is a DNA-targeting agent developed to combat drug-resistant solid tumors, including challenging conditions like glioblastoma multiforme, alongside other solid tumor types such as ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other, REM-001, is a photodynamic therapy specifically targeting cutaneous metastatic breast cancer. The company has forged a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to facilitate the production and sale of VAL-083 within the Chinese market. Incorporated in 2009, Kintara maintains its headquarters in San Diego, California. Its current identity as Kintara Therapeutics, Inc. was adopted in August 2020, succeeding its former name, DelMar Pharmaceuticals, Inc.

Key metrics

Market cap

$11.99M

P/E (TTM)

-0.02

EPS (TTM)

$-11.20

Beta

0.81

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$6.67

200-day avg

$6.02

52-week high

$26.21

52-week low

$0.20

CEO

Jeffrey A. Bacha

ETFs linked to KTRA

Broad-market and Healthcare sector ETFs an investor holding Kintara Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how KTRA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KTRA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Kintara Therapeutics?: Kintara Therapeutics trades under the ticker KTRA on NASDAQ.
Which exchange is KTRA listed on?: KTRA is listed on NASDAQ.
What sector does Kintara Therapeutics operate in?: Kintara Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KTRA in a portfolio?: PortView shows KTRA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.